← Back
$ADPT All transactions

Adaptive Biotechnologies Corp

M 10b5-1 Plan

$ Value

$26K

Shares

2,145

Price

$12

Filed

Feb 6

Insider

Name

PISKEL KYLE

Title

Chief Financial Officer

CIK

0001780662

Roles

Officer

Transaction Details

Transaction Date

2026-02-04

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

218,782

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. | The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

Filing Info

Accession No.

0001780662-26-000002

Form Type

4

Issuer CIK

0001478320

PISKEL KYLE's History

Date Ticker Type Value
2026-02-04 ADPT M $26K
2026-02-04 ADPT $40K
2026-02-04 ADPT M $0
2026-01-12 ADPT M $52K
2026-01-12 ADPT $77K
2026-01-12 ADPT M $0
2025-11-28 ADPT M $78K
2025-11-28 ADPT M $29K
2025-11-28 ADPT M $1.1M
2025-11-28 ADPT $3.2M

Other Insiders at ADPT (90d)

Insider Bought Sold Last
ROBINS CHAD M
CEO and Chairman
$4.1M 2026-04-08
LO FRANCIS
Chief People Officer
$340K 2026-04-08
PISKEL KYLE
Chief Financial Officer
$40K 2026-02-04
RUBINSTEIN JULIE
President and COO
$5.7M 2026-04-21
ROBINS HARLAN S
Chief Scientific Officer
$948K 2026-04-08